Trial · NCT04312503
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"
NCT04312503, Completed, Aziende Chimiche Riunite Angelini Francesco S.p.A
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia". Trials, record NCT04312503. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04312503
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"
- NCT number
- NCT04312503
- Status
- Completed
- Enrollment
- 95 participants, actual
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Conditions
- Schizophrenia
- Interventions
- Lurasidone, aripiprazole, olanzapine, quetiapine or risperidone
- First posted
- 2020-03-18
- Last updated
- 2023-05-06
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in the metabolic parameters | 4 weeks | Change in metabolic syndrome in 3 of 5 parameters: 1. Arterial hypertension defined as. systolic pressure ≥ 130 mmHg and/or diastolic pressure ≥85 mmHg or treatment for hypertension. 2. Waist Circumference ≥ 90 cm in men or ≥ 80 cm in women. 3. Fasting Plasma Glucose ≥5.6 mmol/l and/or known treatment for hyperglycemia. 4. Triglycerides ≥1.7 mmol/l or medication for elevated triglycerides. 5. HDL Cholesterol ≤ 1.0 mmol/l in men and ≤1.3 mmol/l for women or taking medication. |
| Secondary | Retrospective investigation of the metabolic effects of switches to any atypical antipsychotic occurred in the previous 12 months | 12 months before baseline (switch to any atypical antipsychotics) | Change in metabolic syndrome in 3 of 5 parameters: 1. Arterial hypertension defined as. systolic pressure ≥ 130 mmHg and/or diastolic pressure ≥85 mmHg or treatment for hypertension. 2. Waist Circumference ≥ 90 cm in men or ≥ 80 cm in women. 3. Fasting Plasma Glucose ≥5.6 mmol/l and/or known treatment for hyperglycemia. 4. Triglycerides ≥1.7 mmol/l or medication for elevated triglycerides. 5. HDL Cholesterol ≤ 1.0 mmol/l in men and ≤1.3 mmol/l for women or taking medication. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04312503
GET https://conductscience.org/api/trials/v1/NCT04312503/registered